Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management ; volume:20 ; number:1 ; day:3 ; month:10 ; year:2021 ; pages:1-11 ; date:12.2021
Lipids in health and disease ; 20, Heft 1 (3.10.2021), 1-11, 12.2021
- Creator
-
Xu, Yanlan
Yang, Xinyu
Bian, Hua
Xia, Mingfeng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-021-01564-z
- URN
-
urn:nbn:de:101:1-2021120810045282255288
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xu, Yanlan
- Yang, Xinyu
- Bian, Hua
- Xia, Mingfeng
- SpringerLink (Online service)
Other Objects (12)
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
Mechanism and treatment of olfactory dysfunction caused by coronavirus disease 2019
“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD)
Nephrology and Coronavirus Disease 2019
Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Nonalcoholic fatty liver disease and cardiovascular disease risk
Disease, Dysfunction and the Brain
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
Mechanism and treatment of olfactory dysfunction caused by coronavirus disease 2019
“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD)
Nephrology and Coronavirus Disease 2019
Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Nonalcoholic fatty liver disease and cardiovascular disease risk
Disease, Dysfunction and the Brain
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
Mechanism and treatment of olfactory dysfunction caused by coronavirus disease 2019
“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD)
Nephrology and Coronavirus Disease 2019
Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Nonalcoholic fatty liver disease and cardiovascular disease risk